A first-in-human trial on the safety and immunogenicity of COVID-eVax, a cellular response-skewed DNA vaccine against COVID-19 / Egeler, Md; Van Leeuwen, M; Fraterman, I; Van Den Heuvel, Nmj; Boekhout, Ah; Lai-Kwon, J; Wilthagen, Ea; Eriksson, H; Haanen, Jb; Wilgenhof, S; Ascierto, Pa; Van Akkooi, Acj; van de Poll-Franse, Lv. - In: MOLECULAR THERAPY. - ISSN 1525-0016. - (2023). [10.1016/j.ymthe.2022.12.017]
A first-in-human trial on the safety and immunogenicity of COVID-eVax, a cellular response-skewed DNA vaccine against COVID-19
Ascierto PA;
2023
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
